| Literature DB >> 34068739 |
Yu Jin Kim1, Woo-Young Jeon1, Youn-Hwan Hwang1, Mee-Young Lee1.
Abstract
Gyeji-tang (GJT), a traditional herbal formula composed of five herbal medicines, is commonly used to treat the common cold, exogenous febrile disease, fever and headaches in Korea, China and Japan. Although various pharmacological activities of GJT have been reported in several studies, the effect of GJT water extract (GJTWE) on airway inflammation has not yet been investigated. This study aimed to evaluate the effects of GJTWE on airway inflammation-related factors using human bronchial epithelial BEAS-2B cells, and to identify the phytochemicals in GJTWE by ultra-performance liquid chromatography-diode array detector-tandem mass spectrometry (UPLC-DAD-MS/MS) analysis. GJTWE significantly decreased the production of chemokines, including eotaxin-3, eotaxin-1, regulated on activation normal T-cell expressed and secreted (RANTES), and matrix metalloproteinase-9, and the expression of the adhesion molecules, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, in interleukin-4 + tumor necrosis factor-α (IT)-stimulated BEAS-2B cells. In the UPLC-DAD-MS/MS analysis, 21 phytochemicals, including six flavonoids, two chalcones, five terpenoids, six phenolics, one phenylpropanoid and one coumarin, were identified in GJTWE. The findings suggested that GJTWE might exhibit anti-inflammatory effects on airway inflammation by regulating the expression of inflammatory response-related factors in IT-stimulated BEAS-2B cells; further studies are required to determine the bioactive compounds involved in the inhibition of airway inflammation.Entities:
Keywords: BEAS-2B cells; Gyeji-tang; RANTES; UPLC-DAD-MS/MS; airway inflammation; eotaxins; matrix metalloproteinase-9
Year: 2021 PMID: 34068739 PMCID: PMC8151808 DOI: 10.3390/plants10050951
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Phytochemicals identified from GJTWE by UPLC-DAD-MS/MS.
| No. | Rt 1 (min) | Calculated ( | Measured ( | Adduct | Error (ppm) | Formula | MS/MS ( | Identifications |
|---|---|---|---|---|---|---|---|---|
| 1 | 4.32 | 153.0193 | 153.0187 | [M−H]− | −3.9699 | C7H6O4 | 153.0176, 109.0276 | Protocatechuic acid [ |
| 2 | 5.09 | 139.0390 | 139.0389 | [M + H]+ | −0.5419 | C7H6O3 | 139.0388, 121.0285, 111.0443, 93.0340 | Protocatechualdehyde [ |
| 3 | 5.16 | 289.0718 | 289.0710 | [M−H]− | 3.5430 | C15H14O6 | 289.0709, 245.0809, 203.0701, 179.0491, 165.0176, 137.0228 | Catechin [ |
| 4 | 5.93 | 563.1406 | 563.1392 | [M−H]− | −2.5017 | C26H28O14 | 563.1381, 473.1062, 443.0975, 383.0745, 353.0655 | Schaftoside [ |
| 5 | 6.04 | 481.1704 | 481.1698 | [M + H]+ | −1.3305 | C23H28O11 | 179.0700, 151.0752, 133.0648 | Albiflorin [ |
| 6 | 6.28 | 525.1614 | 525.1634 | [M + HCO2]− | 3.8676 | C23H28O11 | 327.1074, 165.0541, 121.0277 | Paeoniflorin [ |
| 7 | 6.67 | 433.1129 | 433.1126 | [M + H]+ | −0.7161 | C21H20O10 | 433.1061, 415.1018, 397.0916, 379.0807, 351.0856, 313.0702 | Isovitexin [ |
| 8 | 6.73 | 549.1614 | 549.1637 | [M−H]− | 4.2543 | C26H30O13 | 549.1605, 417.1173, 255.0652, 135.0069, 119.0487 | Liquiritin apioside [ |
| 9 | 6.85 | 183.0652 | 183.0652 | [M + H]+ | −0.1077 | C9H10O4 | 183.0652, 123.0442 | Syringaldehyde [ |
| 10 | 6.87 | 417.1191 | 417.1182 | [M−H]− | −2.2678 | C21H22O9 | 417.1183, 255.0653, 135.0070, 119.0483 | Liquiritin [ |
| 11 | 7.01 | 939.1109 | 939.1087 | [M−H]− | −2.3388 | C41H32O26 | 769.0862, 617.0756, 447.0557, 295.0450, 169.0126 | 1,2,3,4,6- |
| 12 | 8.65 | 417.1191 | 417.1183 | [M−H]− | 4.0974 | C21H22O9 | 417.1176, 255.0652, 135.0070, 119.0481 | Isoliquiritin [ |
| 13 | 8.80 | 147.0441 | 147.0439 | [M + H]+ | −0.9875 | C9H6O2 | 147.0439, 103.0547, 91.0548, 77.0394, 65.0394 | Coumarin [ |
| 14 | 9.28 | 255.0663 | 255.0656 | [M−H]− | −2.7953 | C15H12O4 | 255.0651, 135.0069, 119.0483 | Liquiritigenin [ |
| 15 | 10.84 | 629.1876 | 629.1862 | [M + HCO2]− | −2.1643 | C30H32O12 | 431.1359, 165.0540, 121.0276 | Benzoylpaeoniflorin [ |
| 16 | 11.14 | 133.0648 | 133.0648 | [M + H]+ | −0.0089 | C9H8O | 133.0647, 115.0544, 105.0702, 103.0546, 91.0548, 79.0550, 77.0394, 55.0188 | Cinnamaldehyde [ |
| 17 | 12.02 | 255.0663 | 255.0671 | [M−H]− | 3.1272 | C15H12O4 | 255.0652, 153.0180, 135.0069, 119.0483 | Isoliquiritigenin [ |
| 18 | 13.18 | 821.3965 | 821.3999 | [M−H]− | 4.1300 | C42H62O16 | 821.3943, 351.0556, 193.0343 | Glycyrrhizin [ |
| 19 | 14.52 | 317.1723 | 317.1720 | [M + Na] + | −0.9535 | C17H26O4 | 317.1690, 299.1064 | 6-Gingerol [ |
| 20 | 17.68 | 277.1798 | 277.1809 | [M + H]+ | 4.0361 | C17H24O3 | 277.2159, 259.2050, 137.0596 | 6-Shogaol [ |
| 21 | 19.02 | 471.3469 | 471.3463 | [M + H]+ | −1.2879 | C30H46O4 | 471.3464, 407.3315, 317.2107, 189.1635 | Glycyrrhetinic acid [ |
1 Rt: retention time (min).
Figure 1UPLC-DAD-MS/MS chromatograms of GJTWE. UV and base peak chromatograms (a) and extracted ion chromatograms in the positive and negative ion modes (b) of the identified phytochemicals. 1: protocatechuic acid; 2: protocatechualdehyde; 3: catechin; 4: schaftoside; 5: albiflorin; 6: paeoniflorin; 7: isovitexin; 8: liquiritin apioside; 9: syringaldehyde; 10: liquiritin; 11: 1;2;3;4;6-O-pentagalloylglucose; 12: isoliquiritin; 13: coumarin; 14: liquiritigenin; 15: benzoylpaeoniflorin; 16: cinnamaldehyde; 17: isoliquiritigenin; 18: glycyrrhizin; 19: 6-gingerol; 20: 6-shogaol; 21: glycyrrhetinic acid.
Figure 2Cytotoxic effects of GJTWE in BEAS-2B cells. BEAS-2B cells were seeded into 96-well plates and treated with various concentrations (31.25, 62.5, 125, 250, and 500 μg/mL) of GJTWE for 24 h. The cell viability was assessed using a CCK-8 kit. The values are expressed as the mean ± SEM.
Figure 3Effects of GJTWE on the production of chemokines in BEAS-2B cells. The cells were pretreated with GJTWE (125, 250, and 500 μg/mL) and then co-stimulated with IL-4 + TNF-α (IT, 50 ng/mL) for 48 h. The levels of h-eotaxin-3 (a), h-eotaxin-1 (b), and h-RANTES (c) released into the culture medium were assessed using commercially available ELISA kits. The values are expressed as the mean ± SEM. ## p < 0.01 versus vehicle-treated cells and * p < 0.05 or ** p < 0.01 versus IT-treated cells.
Figure 4Effects of GJTWE on the activity of MMP-9 in BEAS-2B cells. The cells were pretreated with GJTWE (125, 250, and 500 μg/mL) and then co-stimulated with IL-4 + TNF-α (IT, 50 ng/mL) for 48 h. The cell supernatants were loaded for gelatin zymography. Representative photographs of the MMP-9 activity (a) and MMP-9/MMP-2 band intensities (b) are shown. The values are expressed as the mean ± SEM. ## p < 0.01 versus vehicle-treated cells and ** p < 0.01 versus IT-treated cells.
Figure 5Effects of GJTWE on the expression of adhesion molecules in BEAS-2B cells. The cells were pretreated with GJTWE (125, 250, and 500 μg/mL) and then co-stimulated with IL-4 + TNF-α (IT, 50 ng/mL) for 48 h. The total RNA was isolated, and RT-PCR was performed in order to analyze the expression of ICAM-1 and VCAM-1 at the mRNA level. Representative photographs of the ICAM-1 (a) or VCAM-1 (b) expression, and the band intensities of ICAM-1/GAPDH (c) or VCAM-1/GAPDH (d) are shown. The values are expressed as the mean ± SEM. ## p < 0.01 versus vehicle-treated cells and ** p < 0.01 versus IT-treated cells.